<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Depression is a major chronic psychiatric dis-order affecting nearly 21% of the world population and imposes a substantial health burden on the society (
 <xref rid="ref1" ref-type="bibr" class="xref">1</xref>). People with a depressed mood are characterized by despair, loss of interest in daily working and social relationship, sadness, anxiety, hopelessness, helplessness, and guilt (
 <xref rid="ref2" ref-type="bibr" class="xref">2</xref>). There are three main kinds of classical antidepressants in clinical practice, including tricyclic antidepressants (amitriptyline, nortriptyline, and desipramine), selec-tive serotonin reuptake inhibitors (SSRIs) such as fluoxetine, sertraline, citalopram, and monoamine oxidase inhibitors (MAOIs) including moclobemide and tranylcypromine. Although approved antidepre-ssant drugs are effective, a significant number of people do not efficiently respond. In addition, these drugs are accompanied with many adverse effects (
 <xref rid="ref3" ref-type="bibr" class="xref">3</xref>, 
 <xref rid="ref4" ref-type="bibr" class="xref">4</xref>). Accordingly, there is a need for the development of new drugs with more efficacies and less adverse effects. Natural products displaying antidepressant effects are of great interest and may be important sources of new antidepressant drugs (
 <xref rid="ref5" ref-type="bibr" class="xref">5</xref>, 
 <xref rid="ref6" ref-type="bibr" class="xref">6</xref>).
</p>
